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Mukherjee
Duke University
As big spatial data becomes increasingly prevalent, classical spa-
tiotemporal (ST) methods often do not scale well. While methods
have been developed to account for high-dimensional spatial objects,
the setting where there are exceedingly large samples of spatial obser-
vations has had less attention. The variational autoencoder (VAE),
an unsupervised generative model based on deep learning and ap-
proximate Bayesian inference, fills this void using a latent variable
specification that is inferred jointly across the large number of sam-
ples. In this manuscript, we compare the performance of the VAE
with a more classical ST method when analyzing longitudinal visual
fields from a large cohort of patients in a prospective glaucoma study.
Through simulation and a case study, we demonstrate that the VAE
is a scalable method for analyzing ST data, when the goal is to obtain
accurate predictions. R code to implement the VAE can be found on
GitHub: https://github.com/berchuck/vaeST.
1. Introduction. As high-speed computing and medical imaging be-
come increasingly inexpensive, massive amounts of data are generated that
have to be analyzed and are often spatial in nature (Bearden and Thomp-
son, 2017; Smith and Nichols, 2018). In the case of medical imaging, the
number of patients that can be imaged has sky-rocketed in recent years,
allowing for studies that include images from many thousands of patients
(Van Essen et al., 2013; Miller et al., 2016). The current spatial statistics
literature focuses heavily on scalability in terms of the number of spatial
locations (Banerjee, 2017), however largely ignores the setting where a joint
model is needed for spatiotemporal (ST) data that are generated from a
large cohort. Historically, learning an appropriate generating process in this
setting was untenable, typically leading to simplifying assumptions, such as
point-wise (PW) modeling of locations across time (Fitzke et al., 1996). Re-
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2 BERCHUCK ET AL.
cently, however, such assumptions have become obsolete with advances in
machine learning techniques for image analysis (Salakhutdinov, 2015).
In particular, generative models using deep learning have shown great
promise in modeling complex distributions, p(x), for x = x1:M in some po-
tentially high-dimensional space X . Sampling from X is often intractable,
so instead generative modeling learns a distribution q(x) that can be sam-
pled from and is close to p(x) (Doersch, 2016). As such, generative modeling
can be viewed as an approximate method for performing inference in high-
dimensional contexts, when there is an overwhelming availability of observa-
tions x. Generative modeling, and in particular the variational auto-encoder
(VAE), are well-suited for modeling large cohorts of ST data, because they
can characterize variability in a spatial data source through joint modeling
(Kingma and Welling, 2013).
In this paper, we introduce the VAE as a scalable technique for jointly
modeling large samples of ST data, using longitudinal visual field data from
a large cohort of glaucoma patients. The VAE is not a novel technique and
has been written about extensively, however it has not been described as
a method for ST data. The VAE was designed to learn a data generating
mechanism for a large sample of independent spatial objects, and extensions
to the longitudinal setting are sparse. In this paper, we employ a simple two-
stage approach that extends the VAE to ST data and demonstrate its utility
in large cohorts over conventional ST methods.
In the next section, we introduce the clinical importance of visual fields for
detecting glaucoma progression and discuss various assumptions for model-
ing them. In Section 3, we introduce the VAE from the perspective of gen-
erative modeling and variational Bayes and tailor it for ST data. In Section
4 a simulation study compares the performance of the VAE against a stan-
dard ST model and in Section 5, the VAE is applied to a cohort of glaucoma
patients. Discussion follows in Section 6.
2. Assumptions for Modeling Visual Fields. Glaucoma is an op-
tic neuropathy that is the leading cause of irreversible vision loss worldwide
(Tham et al., 2014). Although damage from glaucoma is irreversible, early
treatment can usually prevent or slow down progression to functional dam-
age and visual impairment (Weinreb et al., 2014, 2016). Being able to accu-
rately generate, or predict, the course of a patient’s vision loss from a small
number of initial fields is important for clinicians when making treatment
decisions, as determining the likely areas of future damage over time helps
inform the impact of the disease on quality of life (Abe et al., 2016).
A patient’s functional vision is most often quantified through visual field
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Fig 1. Presenting the disease course of three example patients using six visual fields evenly
spaced across ten years. Visual acuity is measured using total deviation (TD), with more
negative values indicating worse age-adjusted vision. Note that the fields have been made
square (i.e., padded) for use in the deep learning models.
examinations, a psychophysical procedure that assesses a patient’s field of vi-
sion. Currently, standard automated perimetry (SAP) is the default method
for monitoring functional changes in the disease (Wu et al., 2017). In in
this study, we analyze fields generated from SAP using the Humphrey Field
Analyzer-II (HFA-II; Carl Zeiss Meditec Inc., Dublin, CA). The HFA-II is
an interactive technology that assesses a patient’s reaction as light is sys-
tematically introduced at gridded locations across their visual field. At each
location on the field, light is generated with increasing brightness ranging
from approximately 40 decibels (dB; excellent vision) to 0 dB (near blind-
ness). The patient uses a hand-held trigger to indicate whether the light
stimulus was detected and the machine reports the dimmest stimulus de-
tected at each location. The HFA-II grid has 54 locations, however two
correspond to a natural blind spot (representing the optic disc), resulting in
52 informative points.
Once diagnosed with glaucoma, visual field tests are performed routinely
at clinical visits, yielding complex longitudinal spatial maps that are mon-
itored for signs of glaucomatous progression. In this study, we represent
functional loss on the visual field using total deviation (TD) values, an age-
adjusted measure of sensitivity loss, measured in dB. TD is a continuous
measure, with large negative values indicating losses that are greater than
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the age-expected loss. In Figure 1, the disease course of three example pa-
tients is illustrated using six visual fields evenly spaced across ten years.
At baseline, patient b) has severe vision loss in the central region, while a)
only demonstrates a small area of loss in the superior region, and c) appears
healthy. In terms of patterns of progression, patient a) appears to have the
most variability, with worsening in the superior region, while b) and c) ap-
pear stable across time. In clinical studies, the number of patients monitored
is often in the thousands, requiring scalable modeling techniques that can
properly account for the complexities in the spatial big data.
The phrase “big data” is often too general and requires refining. In the
context of standard geographically referenced spatial data, big data most of-
ten refers to the large, and ever-increasing, number of spatial locations that
make conventional models numerically infeasible, due to expensive matrix
inverse and determinant calculations (Banerjee, 2017). By this point there is
an extensive literature existing that addresses this problem through various
methods, including spectral densities (Fuentes, 2007; Stein, 2012), and ap-
proximate Gaussian processs, such as low-rank representations (Wikle and
Cressie, 1999; Cressie and Johannesson, 2008), and sparsity-inducing ap-
proximations that include covariance tapering (Shaby and Ruppert, 2012),
products of lower dimensional conditional distributions (Vecchia, 1988), and
nearest-neighbors (Datta et al., 2016). The problem has received less atten-
tion in areal data, but has also been a focus in recent years (Bradley et al.,
2015). In this manuscript, our focus shifts to an alternate, but increasingly
important, definition of big data, the sample size of the spatial observations.
This issue is not often addressed in the spatial statistics literature, be-
cause methods are typically motivated by fixed geographical domains, such
as zip-codes or countries (Carlin et al., 2014). In this case, the idea of repli-
cates of the spatial process can only refer to longitudinal observations or
a multivariate response (e.g., multiple outcomes in diseases mapping). A
spatial domain, however, is not restricted to geographical areas as spatial
methods have been applied in numerous other settings, including genetics
(Qian et al., 2003; Tischfield and Keeney, 2012), robot vision (Haralick and
Shapiro, 1992), and medical imaging (Penny et al., 2005; Li et al., 2019).
While these applications may also be subjected to the computational issue
of a large number of spatial locations, a more immediate issue is often the
sample size.
Compared to geographical studies, the large sample sizes in modern med-
ical imaging cohorts pose new complications that deserve special treatment.
In an ideal modeling framework, all of the imaging data could be treated
in unison through a joint model that accounts for within subject variabil-
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ity. This model would be ideal because it could learn the full spectrum of
spatial patterns in the images by borrowing information across all patients,
thus allowing for proper inference, pattern recognition, and prediction of
new images. Unfortunately, this approach is not used, as the combination
of a large sample size and the dimension of the image (often longitudinal
in nature) makes inference numerically intractable, even with modern day
algorithms and computers (Nathoo et al., 2019).
To make the analysis feasible, one of two simplifying assumptions is often
made, i) observations across patients are independent, or ii) images have a
low-dimensional representation that can be modeled in place of the origi-
nal image. There are methods that do not require simplifying assumptions,
mostly using joint Bayesian non-parametrics for fMRI studies (Zhang et al.,
2016b; Warnick et al., 2018). While these joint models properly incorporate
both patient and ST dependencies, they typically result in complex high-
dimensional posteriors and are computationally burdensome. Thus, the ma-
jority of models in the literature use one of the aforementioned simplifying
assumptions.
When making the first assumption the sample size issue is eliminated, re-
turning the modeling to the standard spatial setting with a sample size
of one. This approach has been applied numerous times using standard
parametric spatial/ST methods (Leahy and Qi, 2000; Woolrich et al., 2004;
Sanyal and Ferreira, 2012; Li et al., 2015), and in particular to visual field
data (Betz-Stablein et al., 2013; Zhu et al., 2014; Bryan et al., 2015; Berchuck
et al., 2019b,c). Methods that utilize this assumption have the advantage of
full inference and predictions at the image level, with the obvious downside
of ignoring variability from other patients.
The second assumption motivates a technique for reducing the dimension
of each image into a small set of key features, which can then be used for
inference in place of the original high-dimensional image. This two-stage
technique has been successfully applied in the imaging context using basis
transformations (Zhang et al., 2016a), penalized splines, (Lu et al., 2017),
independent components analysis (Sample et al., 2005), and variable selec-
tion (Bezener et al., 2018), and in particular for visual fields (Yousefi et al.,
2018; Wen et al., 2019). While these methods create useful representations
of the images and can be used for clustering, by requiring inference to be
drawn from the latent features, prediction at the image level is not straight-
forward. In this paper, we demonstrate the utility of the second assumption
for visual field data using deep generative modeling, which improves the
ability to makes predictions at the image level (Goodfellow et al., 2014).
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3. The Variational Auto-Encoder for Spatiotemporal Data. In
this section, we introduce the VAE as a formal generative technique for
ST data. The technique uses a two-stage approach, where the first stage
assumes independence across images and uses the VAE to jointly learn a
latent representation for each spatial object. Then, once the latent features
are obtained they are used in a second stage longitudinal model (e.g., an
autoregressive (AR) model). The advantage of this two-stage approach is
that the latent features can be easily modeled and their predictions can be
used to generate predictions at the image level.
We begin by describing the origin of the VAE in generative modeling using
deep learning and then derive the VAE from its probabilistic beginnings in
variational Bayesian inference. We conclude by describing adaptations to
make the VAE robust for ST data.
3.1. Generative Modeling using Deep Learning. Machine learning tech-
niques, and in particular deep learning, have been booming lately thanks
to their ability to model complex high-dimensional distributions, making
them especially useful for imaging modalities (Radford et al., 2015). The
term deep learning refers to the depth of a neural network, which are the
workhorses of machine learning. Neural networks are highly connected sys-
tems of neurons (or parameters), initially developed to represent biologi-
cal nervous systems. As a representation technique, neural networks process
complex data through simple, but non-linear, transformations to create more
abstract representations of the input data. By combining enough highly non-
linear transformations complex functions can be learned.
As it turns out, neural networks that use a fully-connected (i.e., multi-
layer perceptron) specification, meaning that each neuron is connected to
all of the neurons in the next layer, are prone to overfitting and make in-
ference burdensome due to the large number of interaction terms (LeCun
et al., 2015). As such, the most commonly used network for imaging data
is the convolutional neural network (CNN), a network that models complex
data using a hierarchical structure with each successive layer representing
a progressively simpler set of data patterns (Lee et al., 2009). By using
a hierarchy that accounts for localized dependencies, the CNN has a lower
computational burden and has been shown to be successful in modeling data
with spatial structure (Krizhevsky et al., 2012). While the theory underly-
ing deep learning and CNNs has been around for decades, its reemergence
due to improvements in computational power in recent years makes deep
learning particularly useful for learning the generative process for complex
high-dimensional distributions. (Sarle, 1994).
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The two most popular methods are generative adversarial networks (GAN)
and the VAE (Kingma and Welling, 2013; Goodfellow et al., 2014). Both
methods assume there exists a latent (or compressed) representation of the
image (z), although the assumption is motivated from different perspec-
tives. GANs come from game theory, with the adversarial setting developed
specifically for generating images from high-dimensional spaces, and have
been shown to yield crisp and realistic images (Wu et al., 2016). The general
setup is adversarial, pitting a generator model against a discriminator, both
of which are CNNs. The generator is used to transform a low-dimensional
noise vector (z) into a synthetic image, x˜ ∼ q, which is then fed into the
discriminator along with a true image, x ∼ p, to compute the classification
error (i.e., likelihood that x˜ is a true image from X ). The classification ac-
curacy from the discriminator is then returned to the generator, creating
a solve-able optimization problem (Chen et al., 2016). Although capable of
being a generator for complex spaces X , the GAN can be difficult to use in
practice, because the GAN uses arbitrary noise vectors making it difficult to
generate a particular image x with specific features without searching the
entire latent noise space. A useful review of the GAN in medical imaging is
provided in Yi et al. (2018).
In contrast to GANs, which do not state explicit probability distribu-
tions, the VAE can be formalized probabilistically, and was derived from
variational Bayesian inference (Blei et al., 2017). The VAE is a stochastic
extension of the traditional auto-encoder, which is composed of two neu-
ral networks, x˜ = f(g(x)), that are trained to minimize a reconstruction
error, ||x˜ − x|| (Zhao et al., 2017b). In practice, a latent space is learned
(z = z1:K = g(x), with K  M) that often has an intuitive interpretation
(Rumelhart et al., 1985). The traditional auto-encoder can not be used as
a generator, however, because there is no mechanism for sampling from the
latent space. This is remedied in the VAE through a prior specification on
the latent feature space, both allowing a generative process and also em-
powering the user to control the behavior of the features. Typically, smooth
isotropic priors are used that yield a latent space with disentangled features
that permit clear interpretations (Chung et al., 2015).
3.2. Variational Inference. Inference in the VAE amounts to condition-
ing on the original data and computing the posterior of the latent vari-
able, p(z|x). In many cases we can not compute this distribution, because
of the high dimensionality of x. This can be seen through basic probabil-
ity, p(z|x) = p(z,x)/p(x), as the marginal density p(x) = ∫ p(z,x)dz of-
ten does not have a closed form or requires exponential time to compute.
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As such, typical Bayesian inference methods, such as Markov chain Monte
Carlo (MCMC), are not viable and an alternative is required.
A popular approximate inference technique is variational inference, framed
as an alternative to MCMC. While MCMC inference guarantees asymptot-
ically exact samples from the target distribution, variational inference only
finds a density close to the target, but tends to be faster than MCMC (Blei
et al., 2017). Because of this, variational inference scales more easily to large
data and thus is appealing when modeling high-dimensional spaces, such as
imaging data.
The main idea behind variational inference involves optimization, rather
than the sampling of MCMC. Inference begins by defining a class of densities,
qφ(z), referenced by a parameter φ, often multidimensional. Then variational
inference determines the optimal value of φ by minimizing the Kullback-
Leibler (KL) divergence with respect to the exact posterior (Kullback and
Leibler, 1951),
(3.1) qφ∗(z) =min
φ
KL (qφ(z)||p(z|x)) ,
where KL(q(z)||p(z)) = Eq(z)[log{q(z)/p(z)}]. KL is an information-theoretic
measure of proximity between two densities, which is minimized when q(z) =
p(z). Note that it is not called a distance measure, because of its asymmetry.
Once found, qφ∗(z) can be used as the best approximation to the posterior
within the class of densities, qφ(z).
Unfortunately, computing the objective in Equation 3.1 is not possible,
because it is a function of the intractable marginal density or log evidence
(from information theory), log p(x),
KL (qφ(z)||p(z|x)) = Eqφ(z)[log qφ(z)]− Eqφ(z)[log p(z|x)]
= Eqφ(z)[log qφ(z)]− Eqφ(z)[log p(z,x)] + log p(x).(3.2)
Because this objective can not be optimized, focus has been shifted to an
alternative function obtained by re-organizing Equation 3.2,
(3.3) log p(x)−KL (qφ(z)||p(z|x)) = Eqφ(z)[log p(z,x)]− Eqφ(z)[log qφ(z)].
The right hand side of Equation 3.3 is known as the evidence lower bound
(ELBO), aptly named because it is a lower bound for the log evidence,
log p(x) ≥ ELBO(φ). Maximizing the ELBO is equivalent to minimizing
the KL divergence in Equation 3.1. We rewrite the ELBO to obtain the
commonly used objective in variational inference,
ELBO(φ) = Eqφ(z)[log p(z)] + Eqφ(z)[log p(x|z)]− Eqφ(z)[log qφ(z)]
= Eqφ(z)[log p(x|z)]−KL (qφ(z)||p(z)) .(3.4)
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The objective in Equation 3.4 is a sum of the expected log likelihood of
the data and the KL divergence between the prior for the latent space and
the approximate density qφ(z). This form of the objective is reflective of
the typical balancing act of Bayesian inference viewed through the lens of
regularization, where the objective is to find z that is highly likely under
the likelihood, while remaining close to the prior.
Note that in our introduction of variational inference we assume indepen-
dence across the images, x, which is necessary in the VAE. Longitudinal
dependence is introduced in the second-stage of the two-stage process.
3.3. Variational Autoencoder. The VAE uses the form of the objective
in Equation 3.4 to create a generative framework. In standard variational
inference, the distribution of qφ(z) is specified as a mean-field variational
family, which states that the latent variables are mutually independent. This
assumption is a simplifying tool for inference, however has been shown to
be restrictive and a poor assumption in many circumstances (Neville et al.,
2014). The VAE uses a less restrictive family of distributions to define the
approximate posterior, qφ(z|x), which is now indexed by the original data.
The usual choice is to specify qφ(z|x) = N(µφ(x),Σφ(x)), where µφ(·) and
Σφ(·) are neural networks that map the original high-dimensional data to
the moments of the low-dimensional latent space. This choice is convenient,
because if a Gaussian is chosen for the prior there is a closed form for the
regularization loss (Doersch, 2016). This distribution is referred to as the
encoder, because it is responsible for constraining the original data into the
low-dimensional latent space.
In addition to the encoder, the VAE parameterizes the conditional likeli-
hood as a function of the generative parameters θ, pθ(x|z), also commonly
Gaussian, pθ(x|z) = N(µθ(z),Σθ(z)), with µθ(·) and Σθ(·) neural networks.
This density is referred to as the decoder, because it transforms the latent
space back to the high-dimensional data space. The form of the encoder-
decoder leads to the VAE objective, updated from Equation 3.4,
(3.5) ELBO(φ, θ) =
n∑
i=1
Eqφ(z|xi)[log pθ(xi|z)]︸ ︷︷ ︸
reconstruction
−KL (qφ(z|xi)||p(z))︸ ︷︷ ︸
regularization
.
Both the reconstruction and regularization losses involve a sample from
z ∼ qφ(z|x), which can be interpreted as a set of features describing x. The
reconstruction loss is maximized when pθ(x|z) assigns high probability to the
original x. The regularization loss measures the divergence between qφ(x|z)
and the prior p(z), which allows for control over the posterior. Typically, the
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prior is Gaussian, which encourages the latent features to be smooth. This
prevents qφ(z|x) from simply encoding an identity mapping, instead forcing
a more interesting structure (e.g., patterns on the visual field). Thus, the
VAE objective tries to find a qφ(z|x) that maps x into a useful latent space
which is capable of reconstructing x through pθ(x|z).
Maximizing the objective in Equation 3.5 is performed using stochastic
gradient descent, a form of gradient descent that uses a random set of dat-
apoints at each update {xi}, called minibatches (Duchi et al., 2011). The
derivative with respect to the generative parameter is straight forward using
a standard Monte Carlo estimator, ∇θEqφ(z|xi)[log pθ(xi|z)], as the order of
differentiation and expectation can be exchanged.
The variational parameters, φ, are part of the expectation and there-
fore re-parameterization is required to obtain an estimate of the gradient
with low-variance, ∇φEqφ(z|xi)[log pθ(xi|z)] = ∇φEp()[log pθ(xi|gφ(x, ))] =
Ep()[∇φ log pθ(xi|gφ(x, ))], where z = gφ(x, ) and  ∼ p() (Kingma and
Welling, 2013; Rezende et al., 2014). With the gradient inside the expecta-
tion a Monte Carlo estimate can now be performed on the entire objective.
A nice discussion of Bayesian estimation in the VAE is provided in Polson
et al. (2017).
The maximization procedure for the VAE illuminates its utility as an
extension of the expectation-maximization (EM) algorithm in settings of big
data (Dempster et al., 1977). The EM algorithm, like the VAE, was designed
to find maximum likelihood estimates in models with latent variables. The
first term in the ELBO is the expected complete log-likelihood, which EM
optimizes using the fact that the ELBO is equal to the log-likelihood when
qφ(z) = p(z|x). In the E step, EM computes the expectation of the complete
log-likelihood with respect to qφ(z|x), thus assuming it is computable, an
assumption that is often not sufficient with big imaging datasets. Variational
inference provides an approximation of the intractable posterior, however the
standard mean-field approach requires exact solutions of expectation with
respect to the approximate posterior, which is often itself intractable. The
VAE overcomes this by performing gradient descent based on a sampling
estimate of the gradient, thus making it an efficient method for approximate
posterior inference in almost any model with continuous latent variables.
3.4. Enhancing the VAE. Before using the VAE to model ST data, we
make adjustments that make it more robust. It is known that there are
limitations to the standard VAE that are related to existing limitations of
variational inference, in particular the choice of KL divergence. The KL
divergence has been shown to be too restrictive, and has a tendency of over-
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fitting, leading to a qφ(z|x) that has variance tending to infinity (Zhao et al.,
2017a). Furthermore, it is known that KL divergence behaves poorly if there
is not uniform support over the density (Rosca et al., 2018).
As such, we substitute KL divergence with a metric called maximum
mean discrepancy (MMD), which has been shown to allow the VAE to gen-
erate less fuzzy images. MMD is a measure that takes a positive unique
value if qφ(z|x) 6= p(z), and zero if and only if qφ(z|x) = p(z). MMD is
the distance of the mean moments, µp and µq of the two distributions,
MMD(qφ(z|x)||p(z)) = ||µq − µp||2H, when used in a reproducing kernel
Hilbert space (RKHS), H, and can also be expressed in terms of expec-
tations of kernel functions,
(3.6) Ex,x′∼qφ(z|x)[k(x, x
′)] +Ey,y′∼p(z)[k(y, y′)]− 2Ex∼qφ(z|x),y∼p(z)[k(x, y)].
Note that this formulation does not assume any form of the input distribu-
tions, but just requires a kernel function whose feature space is a RKHS. In
this paper, we choose the Gaussian kernel, k(x, x′) = exp{|x − x′|/(2τ2)},
where τ2 is a fixed tuning parameter. The interpretation of the MMD dis-
tance is that when two distributions are identical, their average distance
between samples from each distribution should be close to the average dis-
tance between mixed samples from both distributions.
In addition to the MMD specification, we make changes to the standard
encoder-decoder specification. For the decoder, we simplify the standard
specification by allowing a constant variance, pθ(x|z) = N(µθ(z), σ2I), with
µθ(·) a neural network. This specification simplifies the reconstruction loss
to a squared distance, ||x − µθ(x)||2. This simplification may not be ap-
propriate for all contexts, but for imaging data interest lies in a de-noised
representation of the original data. For the encoder, we specify a determin-
istic function, qφ(z|x) = µφ(x), where µφ is a neural network. The encoder
can be seen as a form of error propagation, that learns a transformation of
a random variable, µφ : x→ z, where distributional assumptions are placed
on z through a prior. This specification was chosen because of our interest
in prediction of longitudinal images. The form of the VAE is presented in
Figure 2.
3.5. A Two-Stage Approach. To model longitudinal images (or ST data
in general) we used a two-stage process by modeling the posterior latent
space learned from the VAE. We begin by defining longitudinal notation,
where an image and the set of l latent features at a visit are xt and zt, re-
spectively, for t = 1, . . . , T . The number of latent features, l, is user specified
and context specific.
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Fig 2. Presenting a variational autoencoder (VAE) for visual field data. The latent space
of the VAE is learned by optimizing both the reconstruction and regularization losses.
The first step of the two-stage process is the estimation of the latent
features (zt) using the VAE, which assumes independence across images.
Then the second step models the latent features longitudinally. Any number
of methods could be used for a longitudinal model that account for temporal
dependencies and the latent feature dimension, including an AR model.
However, we have found that independent linear regressions across each
latent dimension proves sufficient.
This two-stage approach allows for each dimension of the latent space to
independently obtain a future prediction of the latent features at some future
clinical visit, zT+1. Because of the generative properties of the VAE, this
allows for a prediction of a de-noised future visual field using the decoder,
xT+1 = µθ(zT+1). In the following simulation study and data application
we compare this prediction technique to more established methods.
4. Simulation Study. The purpose of the simulation study is to inves-
tigate the performance of the two-stage VAE method for modeling longitu-
dinal series of spatial objects, like visual fields. The advantage of the VAE
is that it can be trained on a large sample of data, allowing it to thoroughly
learn a data generating process, which can then be applied to new samples
for prediction. In contrast, standard ST methods are fit independently to
individual data samples, which is advantageous because inference and pre-
diction are based on the variability of the particular data sample. However,
because they treat the samples as independent they are potentially disad-
vantaging themselves by not using the full spectrum of samples for inference.
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This simulation study demonstrates the utility of both of these methods.
We simulated data from three data generating process, i) a true ST pro-
cess, ii) PW regression at each location, and iii) the two-stage VAE. Fur-
thermore, we specified a setting that dictates the number of temporal visits,
using three (minimum number required) and eight (average in our visual
field dataset), with all visits equally spaced. For each simulation setting, we
simulated 500 datasets, each of which represent the follow-up from one pa-
tient. Furthermore, unlike the ST and PW models, the VAE requires training
data, so we define four varieties of the VAE that are trained on 500, 1,000,
5,000, and 10,000 additional datasets. This yields six methods for compari-
son, i) ST, ii) PW, iii) VAE-500, iv) VAE-1k, v) VAE-5k, and vi) VAE-10k.
To compare the methods across the varying simulation settings, we looked
at two summary metrics, residual standard error from the model fit and pre-
diction error, measured as mean absolute error (MAE) for predicting three
visits into the future.
To simulate ST data we used the model of Rushworth et al. (2014), which
represents ST structure with a multivariate first order autoregressive process
with a spatially correlated precision matrix. In particular, for this simulation
study we specified the following data generating process for an observation,
xit, at location i and time t, for i = 1, . . . ,m and t = 1, . . . , T ,
xit = β + φit + it, it
iid∼ N(0, η2)
φt|φt−1 ∼ N(ψφt−1, τ2Q(W, ρ)−1), t = 1, . . . , T
φ1 ∼ N(0, τ2Q(W, ρ)−1)(4.1)
η2, τ2 ∼ IG(1, 0.1), ρ, ψ ∼ U(0, 1), β ∼ N(0, 1000).
In this model φt = (φ1t, . . . , φmt)
T is the vector of random effects for
time period t, which evolve over time via a multivariate first order AR
process with temporal AR parameter ψ. The temporal autocorrelation is
thus induced via the mean ψφt−1, while spatial autocorrelation is induced
through the covariance τ2Q(W, ρ)−1. The corresponding precision matrix
Q(W, ρ) was proposed by Leroux et al. (2000) and has algebraic form,
Q(W, ρ) = ρ[diag(W1) −W] + (1 − ρ)Im, with W a spatial proximity
(or adjacency) matrix, with each entry [W]jk = 1(j ∼ k), where j ∼ k
indicates that locations j and k are neighbors.
To generate from Equation 4.1, we sampled values of the true parameters,
β, τ2, η2, ρ, and ψ for each simulated dataset. All of the parameters are sam-
pled from a standard normal distribution (or log-normal distribution for the
variances) with the spatial and temporal correlation parameters truncated
between zero and one. This produced a dataset with a variety of spatial and
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temporal levels. For each sample of the parameters, a dataset is simulated.
We attempted to make all of the datasets reflective of visual field data, so
we set the spatial dimension to the number of locations on the visual field,
m = 52, and the adjacency matrix is specified using adjacencies of the visual
field, where two locations are considered neighbors if they share an edge or
corner.
To simulate from the PW setting, we sampled location specific slopes,
intercepts, and mean-squared errors from a standard normal distribution
(or log-normal for the variance), and then generated a joint dataset from
the independent samples across locations.
Finally, we simulated data from the VAE. To obtain realistic datasets,
we defined the encoder and decoder using trained parameters from the data
analysis of visual fields from Section 5. Then, to generate datasets we sim-
ulated latent features and used the decoder to generate the simulated lon-
gitudinal visual field objects. To simulate the latent features we randomly
sampled slopes, intercepts, and mean-squared errors (similar to the PW
method) for the parameters of the linear regressions. These samples needed
more refinement, so instead of being centered at zero, the sampling distri-
butions were centered at the mean values of the posterior latent variables
(for healthy, suspect, and glaucoma) obtained from the actual data analysis
in the following section.
The simulation results are presented in Figure 3, for residual standard
error (left) and prediction error (right). For both metrics, a boxplot summary
is presented for each of the six methods across the simulation settings. In
the figure, the data generating process changes across rows and the columns
indicate different numbers of temporal visits. When looking at the residual
standard error results, ST has the best performance, effectively across all
settings. The VAE begins to have similar performance as the training sample
size increases, although when there are more temporal visits the training
sample size becomes less crucial.
A quick glance at the prediction results illuminate the true potential of
the VAE. While ST predicts well in data generated from the ST model,
it performs worse in the PW and VAE settings, especially when there are
fewer visits. Meanwhile, the VAE has robust prediction properties irrespec-
tive to the data generating mechanism, especially in the settings with fewer
visits. When there are only three visits the VAE has stable prediction re-
gardless of the simulation setting, as long as the number of training samples
is sufficiently large. Here, we see that when the number of temporal visits is
small (3) at least one-thousand training samples are required, while a large
number of visits (8) necessitates a smaller training set. The results indicate
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Fig 3. Demonstrating the properties of the VAE through simulation using residual stan-
dard error (left) and prediction error (right), given by mean absolute error (MAE). For
both metrics, a boxplot summary is presented for each of the six methods across the sim-
ulation settings. In the figure, the data generating process changes across rows and the
columns indicate different numbers of temporal visits. The scale of the y-axis is simulation
dependent and results should generally be interpreted within simulation setting.
that with a sufficient training sample size the VAE has potential for being
a prediction model in general ST settings.
5. VAE in Glaucoma: A Clinical Impact. In this paper, we use
visual fields from participants enrolled in a prospective longitudinal study
designed to evaluate functional impairment in glaucoma. The study includes
29,161 visual fields from 3,832 patient eyes with an average (SD) of 7.61
(7.35) clinical visits and 4.95 (5.25) years of follow-up. In the study there are
healthy, (17%) suspect (58%), and glaucoma (25%) patients. The training,
validation, and test datasets were created by randomly sampling patients
from the overall study population with 80%, 10%, and 10% probability,
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respectively. The randomization process was performed at the patient level,
so that all images from a patient are included in at most one dataset. To
be used in modern deep learning methods, visual fields are made square by
padding the visual field with -37 (the minimum TD value), creating a 12 x
12 square. Prior to analysis, all visual fields were normalized to be in the
range of zero and one.
The neural networks used in the encoder and decoder are deep networks.
The encoder network, µφ, is comprised of two 2D convolutional layers, a
reshaping layer and a fully-connected dense layer, while the decoder network,
µθ, starts with a fully-connected dense layer, followed by a reshaping layer,
and then a sequence of de-convolutions, which up-sample until the original
12 x 12 dimension is reached. All layers use a 3 x 3 kernel size and a stride of
two, and the activation is a rectified non-linear unit transformation, except
for the final levels of the encoder and decoder, which used the identity and
sigmoid activations, respectively. The dimension of the latent space must be
user specified and was chosen to be eight based on Berchuck et al. (2019a),
which showed that it is optimal for visual field data.
The model was trained using the Adam optimizer, an extension of stochas-
tic gradient descent, using 50 epochs and a batch size of 100 (Kingma and
Ba, 2014); we used a learning rate of 1e-4. The training epoch with the mini-
mal validation loss was chosen as optimal. The VAE was implemented using
the deep learning library Keras (version 2.2) (Chollet et al., 2015) with Ten-
sorflow (version 1.9) (Abadi et al., 2016) backend, all within RStudio (3.5.1)
(RStudio Team, 2015). Example code can be found at the following GitHub
repository: https://github.com/berchuck/vaeST.
Before exploring the prediction properties of the VAE, we investigated
the interpretation of the latent space and the usefulness of the generative
process for understanding disease progression. In Figure 4a, the posterior
distribution of each of the latent dimensions is presented across disease sta-
tus. This display indicates the clinical utility of the VAE latent space as each
of the dimensions are different across diseases status, with the glaucoma pa-
tients prominently skewed away from the origin. Interpreting each of these
dimensions independently is problematic, however, due to the dependencies
of the encoder-decoder process.
As such, it is useful to investigate the joint latent space, which helps
to explain the dependencies across the dimensions. While the full eight-
dimensional space cannot be displayed, the pairwise comparisons can, so in
Figure 4b we present an example comparison using latent dimensions two
and four. The healthy patients generally reside near the origin, while suspects
inhabit the space right off the origin and glaucoma patients fill out the
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Fig 4. Clinical utility of the VAE latent space. a) Boxplots of the latent dimensions across
disease status. b) Scatterplot of latent dime sions two and four, again across disease sta-
tus. Data from the training and test process are included.
remaining space. The interpretability of the latent space is particular useful
for clustering visual fields across varying disease status, and additionally
since the latent space of the VAE is generative it can be used for prediction.
The generative process of the VAE is presented in Figure 5. The figure
shows the latent space across the second and fourth dimensions (same as
Figure 4b) for the test dataset. Presented across the space at their corre-
sponding latent variables are a selection of decoded visual fields; the blue
ones correspond to the patient in Figure 1a. This presentation provides lon-
gitudinal context to the presentation of Figure 4b, as the trajectory of the
example patient through the latent space is now visualized. This gives cre-
dence to the two-stage prediction process as movement through the latent
space clearly corresponds to progression patterns of the visual field.
Prediction accuracy was determined by predicting five consecutive and
immediately succeeding follow-up visits from the third, fifth, and eighth vis-
its, resulting in fifteen comparisons. Analyses included all patients in the test
dataset, although each prediction only included patients with the sufficient
number of visits. For example, the prediction of the fifth visit using only the
first three, included only patients with at least five visits. We also looked
at prediction accuracy in glaucoma patients only. Prediction accuracy was
assessed using MAE for only the 52 informative locations (i.e., not the full
12 x 12 image). The VAE results are compared to the ST model introduced
in Section 4 and PW regression.
Prediction results are presented in Figure 6, where each row indicates the
number of visits used for prediction (top: 3, middle: 5, bottom: 8), with
the column indicating how far into the future the prediction is for (ranging
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Fig 5. Demonstrating the utility of the VAE generative process for predicting trajectories
and patterns of visual field progression. A selection of decoded visual fields are presented
across the second and fourth dimension. The points represent the encoded visual fields from
the test dataset. The blue visual fields represent the trajectory of the patient in Figure 1a.
from 1-5). The MAE generally become smaller as the number of visits used
increases and the length of the prediction decreases. In general, the VAE
has improved prediction accuracy over the ST and PW methods, but in
particular this pattern becomes more pronounced when fewer base visits are
used to predict further into the future, and in patients with glaucoma. For
example, when predicting three to five visits into the future for glaucoma
patients using only three visits, the VAE is particularly preferred over ST
and PW. These results are impactful, because when glaucoma patients are
diagnosed it is important to understand their progression pattern in the
early years from diagnosis to limit quick acting progression.
Based on these prediction results it is clear that the VAE is an appropriate
model to use for visual field data, especially for prediction. This indicates
that the two-stage VAE process is capable of removing variability due to
spatial patterns in the process of producing encoded realizations. This is
an appealing characteristic, reminiscent of smoothing that occurs in typical
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Fig 6. Accuracy for predictions of future glaucoma progression using visual fields. Predic-
tions are presented in mean absolute error (MAE) for the VAE, ST, and PW methods.
Each row indicates the number of visits used for prediction (top: 3, middle: 5, bottom: 8),
with the column indicating how far into the future the prediction is for (ranging from 1-5).
ST methods. To demonstrate the smoothing that occurs in the VAE, we
present the raw and decoded empirical spatial and temporal correlation of
visual fields for an example patient in Figure 7. This figure indicates that
the decoded (i.e., de-noised) visual fields are representations of the original
visual field with spatial variability removed, making for robust predictions.
6. Discussion. In this article we proposed the VAE as a scalable model
for settings with large samples of ST data, in particular applying it to visual
field data to assess trajectories and patterns of glaucoma progression. By
combining approximate techniques rooted in variational Bayesian inference
and deep generative learning, the VAE was capable of quickly learning a joint
model for large samples of high-dimensional data. In contrast to standard
ST methods that assume independence between samples, the VAE modeled
the data jointly and was able to learn an interpretable latent representation
for visual fields, which proved to be useful for prediction purposes.
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Fig 7. Demonstrating the spatial smoothing in the decoded visual fields. Presented are the
a) raw and b) decoded empirical spatial (upper diagonal) and temporal (lower diagonal)
correlations for an example patient.
The latent space learned in the VAE was shown to be clinically useful
as a method for clustering visual fields by disease status (Figure 4). The
scatterplot representation of the latent space was enhanced by decoding a
handful of latent variables into their corresponding de-noised visual fields
(Figure 5). This presentation provided context pertaining to the patterns of
progression, as an increase (decrease) in the fourth (second) dimension in-
dicated worsening in the superior (inferior) hemisphere, while both dictated
a global worsening on the visual field.
Analyzing the latent space is useful, however in order to assess disease
progression it became important to understand longitudinal trajectories
through the space. Typically methods that use dimension reduction tech-
niques to make predictions are forced to interpret the results at the latent
level, however the VAE does not suffer this restriction due to its generative
nature; instead, using a two-stage technique to produce de-noised visual
fields. The utility of this method was exemplified through the example pa-
tient in Figure 5, whose longitudinal decoded visual fields are presented
across the latent space, indicating a worsening in the superior region.
Through simulation, we demonstrated that the VAE is a robust method
for predicting ST data objects across various data generating settings (Fig-
ure 3). In contrast, typical ST methods that are fit independently to each
data object, are less generalizable, performing well in their own data gen-
erating setting, but have unreliable prediction accuracy otherwise. ST was
more robust when comparing residual standard error, a measure of model
fit. This disparity helps to clarify the appropriate setting for the ST or VAE
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methods. The assumptions that lead to the ST method, permit it to draw
inference based on the data that was used to fit the model, therefore, it
follows that it would have ideal model fit. In contrast, the VAE is trained
based on a large sample size of similar data objects and then applied to new
data. This process may not be advantageous to model fit, however through
its training process it better learns the full spectrum of patterns in the data,
and therefore has more robust predictions.
This phenomena bore out in the simulation, was also observed when an-
alyzing visual field data. Based on the results of the simulation, it was not
surprising that the VAE had superior prediction performance over the ST
and PW models, thanks to the large sample size of visual fields included
in the study (Figure 6). Nonetheless, it was encouraging that the VAE per-
formed best in patients with glaucoma and in the early period from baseline
visit. While this a particularly important time clinically, it is often the most
difficult period to make reliable predictions, because of the small number
of visits. That the VAE performed well in this setting is a testament to its
generative framework which is capable of producing smoothed predictions
(Figure 7).
In the manuscript, a potential limitation is that we present de-noised
predictions. In the future, it may be useful to explore different covariances
types in the decoder (i.e., Σθ(·)). While this would be a useful exercise, in
analyses of images (or general medical procedures, like visual fields), the
de-noised images are often desired. Another potential limitation is that we
treated each of the visual fields as independent images when training the
VAE. In the future, extending the VAE to learn latent representations of
longitudinal series of visual fields would be useful for clustering full samples,
not single images.
In conclusion, this manuscript showed the potential use of the VAE as
a scalable alternative to standard ST methods in the setting of big data,
where there may be a combination of a high-dimensional object and large
samples. As a combination of recent advances in deep learning, approximate
Bayesian inference, and modern computational algorithms, the VAE offers
scalability that conventional ST methods lack and will become more popular
with the incessant production of data in our modern age.
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